Carbon Clean Solutions USA, Inc. – Trademark Portfolio
Entity Type: 03
Carbon Clean Solutions USA, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CDRMAX, APBS-CARBEX, and APBS-CDRMAX. The owner is based in Chicago, IL.
1712 N. Wood St., Unit 2E
Chicago, IL 60622
Showing of trademarks Trademarks
Trademark Classifications
Carbon Clean Solutions USA, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Carbon Clean Solutions USA, Inc. have?
Carbon Clean Solutions USA, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does Carbon Clean Solutions USA, Inc. file in?
Carbon Clean Solutions USA, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Carbon Clean Solutions USA, Inc.'s most well-known trademarks?
Carbon Clean Solutions USA, Inc.'s registered trademark portfolio includes well-known marks such as CDRMAX, APBS-CARBEX, and APBS-CDRMAX. These are among 3 currently registered trademarks in the portfolio.
What is Carbon Clean Solutions USA, Inc.'s trademark registration success rate?
Carbon Clean Solutions USA, Inc. has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.